Ashok Sharma

About

Motivated team leader experienced applying in both In-vivo and In-vitro Molecular Biology and Cancer Epigenetics & DNA methylation lab setting and more than two years experience in Pharmacology & Toxicology field during Diploma in Pharmacy. I am prestigious “DBT- Ramalingaswami fellowship” and “DST-Ramanujan fellowship” awardee from Govt. of India. I have National & International collaboration with reputed universities to execute high priority research project. Major areas of experience, strengths and skills include: cancer epigenetics, DNA methylation, Cancer-germline antigen, Pyro-& Next- Generation sequencing, cell signaling; EMT, drug metabolism; working knowledge of pharmacological & diagnostic assays; At present, I am delivering the diagnostic service to the patients. Recently, I have introduced the genetic diagnostic test like TPMT test, BRCA profiling (3 Founder mutations), Ataxia profiling, MLPA based diagnostic test for different cancer; neurological disorder in Division of Neurobiochemistry

Employment

• All India Institute of Medical Sciences Professor
  2025 - Present
• University of Nebraska Medical Center Postdoctoral Fellow
  2012 - 2015
• Vanderbilt University Medical Center Postdoctoral Fellow
  2009 - 2012

Education

• All India Institute of Medical Sciences Ph.D
  2004 - 2008

Projects & Funding

Projects & funding information is unavailable.

Publications (25)

• SUV family histone methyltransferases correlate with nuclear lamina remodeling and clinical outcome in cancer: integrative pan-cancer TCGA analysis and experimental evidence
  Scientific Reports 2026 DOI: 10.1038/s41598-026-44020-7
  +Save
• Diagnostic accuracy of artificial intelligence in detection of ovarian cancer-a pilot study.
  Frontiers in medicine 2026 DOI: 10.3389/fmed.2026.1729412
  +Save
• Rewiring cancer epigenome: lncRNA as modulator of chromatin architecture and neoplastic transformation
  Mammalian Genome 2026 DOI: 10.1007/s00335-025-10172-6
  +Save
• Probing and enhancing tumor-infiltrating lymphocytes: insights from single-cell technologies and genetic reprogramming
  Exploration of Immunology 2025 DOI: 10.37349/ei.2025.1003227
  +Save
• Pan-cancer TCGA analysis reveals the potential involvement of B-type lamins in dysregulating chromosome segregation in human cancer
  Mammalian Genome 2025 DOI: 10.1007/s00335-024-10086-9
  +Save
• Notch3 and Its Clinical Importance in Ovarian Cancer
  Drugs and Drug Candidates 2024 DOI: 10.3390/ddc3040040
  +Save
• Cellular and epigenetic perspective of protein stability and its implications in the biological system
  Epigenomics 2024 DOI: 10.1080/17501911.2024.2351788
  +Save
• Surface functionalization of gallium nitride for biomedical implant applications
  Applied Surface Science 2023 DOI: 10.1016/j.apsusc.2022.155858
  +Save
• BESFA: bioinformatics based evolutionary, structural & functional analysis of Prostate, Placenta, Ovary, Testis, and Embryo (POTE) paralogs
  Heliyon 2022 DOI: 10.1016/j.heliyon.2022.e10476
  +Save
• An efficient immunoassay for the B cell help function of SARS-CoV-2-specific memory CD4+ T cells
  Cell Reports Methods 2022 DOI: 10.1016/j.crmeth.2022.100224
  +Save